Quarterly report · Q3
2370.TEDINET S100P0C7
Period2021-10-01 → 2022-06-30
Filed2022-08-12
StandardJapan GAAP
ConsolidatedNo
Data checks10 of 10 passed
Key figures · 34
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥470m | 2021-10-01 → 2022-06-30 | Standalone | Net sales |
| Revenue | ¥683m | 2020-10-01 → 2021-09-30 | Standalone | Net sales (5-year summary) |
| Revenue | ¥512m | 2020-10-01 → 2021-06-30 | Standalone | Net sales |
| Operating income | −¥988m | 2021-10-01 → 2022-06-30 | Standalone | Operating income |
| Operating income | −¥792m | 2020-10-01 → 2021-06-30 | Standalone | Operating income |
| Ordinary income | −¥984m | 2021-10-01 → 2022-06-30 | Standalone | Ordinary income |
| Ordinary income | −¥871m | 2020-10-01 → 2021-09-30 | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥577m | 2020-10-01 → 2021-06-30 | Standalone | Ordinary income |
| Profit before tax | −¥985m | 2021-10-01 → 2022-06-30 | Standalone | Income before income taxes |
| Profit before tax | −¥545m | 2020-10-01 → 2021-06-30 | Standalone | Income before income taxes |
| Net income | −¥989m | 2021-10-01 → 2022-06-30 | Standalone | Profit loss |
| Net income | −¥843m | 2020-10-01 → 2021-09-30 | Standalone | Net income loss (5-year summary) |
| Net income | −¥549m | 2020-10-01 → 2021-06-30 | Standalone | Profit loss |
| Total assets | ¥6.3bn | at 2022-06-30 | Standalone | Assets |
| Total assets | ¥5.4bn | at 2021-09-30 | Standalone | Assets |
| Total assets | ¥5.7bn | at 2021-06-30 | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥539m | at 2022-06-30 | Standalone | Liabilities |
| Total liabilities | ¥475m | at 2021-09-30 | Standalone | Liabilities |
| Net assets / equity | ¥5.7bn | at 2022-06-30 | Standalone | Net assets |
| Net assets / equity | ¥4.9bn | at 2021-09-30 | Standalone | Net assets |
| Net assets / equity | ¥5.2bn | at 2021-06-30 | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥4.8bn | at 2022-06-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥4.1bn | at 2021-09-30 | Standalone | Cash and deposits |
| EPS (basic) | ¥-5.11 | 2021-10-01 → 2022-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-1.5 | 2022-04-01 → 2022-06-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-4.88 | 2020-10-01 → 2021-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-3.21 | 2020-10-01 → 2021-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-0.22 | 2021-04-01 → 2021-06-30d | Standalone | Basic earnings loss per share (5-year summary) |
| Equity ratio | 91.4% | at 2022-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 90.8% | at 2021-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 91.2% | at 2021-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 211,730,423 | at 2022-06-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 178,750,423 | at 2021-09-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 177,730,423 | at 2021-06-30 | Standalone | Total number of issued shares (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 20
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2021-10-01 → 2022-06-30 | −¥386m |
| jpcrp040300-q3r_E05351-000Cellular And Tissue Based Product Businessreportable segment | revenue | 2021-10-01 → 2022-06-30 | ¥194,000 |
| jpcrp040300-q3r_E05351-000Cellular And Tissue Based Product Businessreportable segment | revenue external | 2021-10-01 → 2022-06-30 | ¥194,000 |
| jpcrp040300-q3r_E05351-000Cellular And Tissue Based Product Businessreportable segment | segment profit | 2021-10-01 → 2022-06-30 | −¥425m |
| jpcrp040300-q3r_E05351-000Contract Cell Manufacturing Businessreportable segment | revenue | 2021-10-01 → 2022-06-30 | ¥470m |
| jpcrp040300-q3r_E05351-000Contract Cell Manufacturing Businessreportable segment | revenue external | 2021-10-01 → 2022-06-30 | ¥470m |
| jpcrp040300-q3r_E05351-000Contract Cell Manufacturing Businessreportable segment | segment profit | 2021-10-01 → 2022-06-30 | −¥178m |
| —segment total | revenue | 2021-10-01 → 2022-06-30 | ¥470m |
| —segment total | revenue external | 2021-10-01 → 2022-06-30 | ¥470m |
| —segment total | segment profit | 2021-10-01 → 2022-06-30 | −¥603m |
| Reconciling Itemsreconciling | segment profit | 2020-10-01 → 2021-06-30 | −¥385m |
| jpcrp040300-q3r_E05351-000Cellular And Tissue Based Product Businessreportable segment | revenue | 2020-10-01 → 2021-06-30 | ¥143,000 |
| jpcrp040300-q3r_E05351-000Cellular And Tissue Based Product Businessreportable segment | revenue external | 2020-10-01 → 2021-06-30 | ¥143,000 |
| jpcrp040300-q3r_E05351-000Cellular And Tissue Based Product Businessreportable segment | segment profit | 2020-10-01 → 2021-06-30 | −¥319m |
| jpcrp040300-q3r_E05351-000Contract Cell Manufacturing Businessreportable segment | revenue | 2020-10-01 → 2021-06-30 | ¥512m |
| jpcrp040300-q3r_E05351-000Contract Cell Manufacturing Businessreportable segment | revenue external | 2020-10-01 → 2021-06-30 | ¥512m |
| jpcrp040300-q3r_E05351-000Contract Cell Manufacturing Businessreportable segment | segment profit | 2020-10-01 → 2021-06-30 | −¥88m |
| —segment total | revenue | 2020-10-01 → 2021-06-30 | ¥512m |
| —segment total | revenue external | 2020-10-01 → 2021-06-30 | ¥512m |
| —segment total | segment profit | 2020-10-01 → 2021-06-30 | −¥407m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 318
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report non consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)普 賢 監 査 法 人 | |
| Cpa1 audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)嶋田 両児 | |
| Cpa2 audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)髙橋 弘 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration_NonConsolidatedMember | 512256000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration_NonConsolidatedMember | 469785000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration_NonConsolidatedMember | 683033000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration_NonConsolidatedMember | -577464000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration_NonConsolidatedMember | -984160000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration_NonConsolidatedMember | -870726000 | JPY |
| Net income loss (5-year summary) | Prior1YTDDuration_NonConsolidatedMember | -548783000 | JPY |
| Net income loss (5-year summary) | CurrentYTDDuration_NonConsolidatedMember | -988743000 | JPY |
| Net income loss (5-year summary) | Prior1YearDuration_NonConsolidatedMember | -843396000 | JPY |
| Equity in earnings losses of affiliates if equity method is applied (5-year summary) | Prior1YTDDuration_NonConsolidatedMember | － | JPY |
| Equity in earnings losses of affiliates if equity method is applied (5-year summary) | CurrentYTDDuration_NonConsolidatedMember | － | JPY |
| Equity in earnings losses of affiliates if equity method is applied (5-year summary) | Prior1YearDuration_NonConsolidatedMember | － | JPY |
| Capital stock (5-year summary) | Prior1QuarterInstant_NonConsolidatedMember | 5046568000 | JPY |
| Capital stock (5-year summary) | CurrentQuarterInstant_NonConsolidatedMember | 5892020000 | JPY |
| Capital stock (5-year summary) | Prior1YearInstant_NonConsolidatedMember | 5082073000 | JPY |
| Total number of issued shares (5-year summary) | Prior1QuarterInstant_NonConsolidatedMember | 177730423 | |
| Total number of issued shares (5-year summary) | CurrentQuarterInstant_NonConsolidatedMember | 211730423 | |
| Total number of issued shares (5-year summary) | Prior1YearInstant_NonConsolidatedMember | 178750423 | |
| Net assets (5-year summary) | Prior1QuarterInstant_NonConsolidatedMember | 5167376000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant_NonConsolidatedMember | 5726175000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant_NonConsolidatedMember | 4902726000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant_NonConsolidatedMember | 5663742000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant_NonConsolidatedMember | 6265188000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant_NonConsolidatedMember | 5377672000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration_NonConsolidatedMember | -3.21 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration_NonConsolidatedMember | -5.11 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration_NonConsolidatedMember | -4.88 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration_NonConsolidatedMember | － | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration_NonConsolidatedMember | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration_NonConsolidatedMember | － | |
| Dividend paid per share (5-year summary) | Prior1YTDDuration_NonConsolidatedMember | － | |
| Dividend paid per share (5-year summary) | CurrentYTDDuration_NonConsolidatedMember | － | |
| Dividend paid per share (5-year summary) | Prior1YearDuration_NonConsolidatedMember | － | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant_NonConsolidatedMember | 0.912 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant_NonConsolidatedMember | 0.914 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant_NonConsolidatedMember | 0.908 | |
| Basic earnings loss per share (5-year summary) | Prior1QuarterDuration_NonConsolidatedMember | -0.22 | |
| Basic earnings loss per share (5-year summary) | CurrentQuarterDuration_NonConsolidatedMember | -1.50 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 211730423 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 211730423 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 211730423 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 211730423 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 10 of 10 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |